GeminIQ Website Logo

Viewing ALMR free

Subscribe for full history, 90+ metrics, screener, watchlist...

Alamar Biosciences, Inc.

ALMR

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
13365
Accounts Receivable Net Current
2020
Inventory Net
4540
Prepaid Expense And Other Assets Current
1617
Assets Current
331141
Restricted Cash
65
Property Plant And Equipment Net
1310
Operating Lease Right Of Use Asset
3626
Capitalized Computer Software Net
22
Other Assets Noncurrent
32
Assets
391186
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
146
Accrued Liabilities And Other Liabilities
1217
Operating Lease Liability Current
22
Liabilities Current
2824
Operating Lease Liability Noncurrent
3929
Convertible Debt
-65
Other Liabilities Noncurrent
11
Liabilities
78130
Temporary Equity Carrying Amount Attributable To P…
-235
Stockholders Equity
Common Stock Value
00
Additional Paid In Capital
51612
Accumulated Other Comprehensive Income Loss Net Of…
-0-0
Retained Earnings Accumulated Deficit
-203-190
Stockholders Equity
313-178
Liabilities And Stockholders Equity
391186

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
2026-14.69%11.31%8.01%---

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
11.85
5.88
Quick Ratio
9.67
3.50
Working Capital
303.42M
117.43M
Leverage & Debt
Debt to Equity
0.25
-0.73
Debt Ratio
0.20
0.69
Valuation Metrics
P/B TTM
5.08
-
Market Cap
1.59B
-
Enterprise Value
1.46B
-
Calculated Values
Net Debt
-132.97M
508.00K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-04-20Purchase
Owner: Naclerio, Nicholas
Title: -
Shares: 235,294
Price/Share: $17.00
Value: $3,999,998.00
Shares Owned: 507,076
Relationship: Director
Ownership: Indirect
2026-04-20Purchase
Owner: Illumina, Innovation Fund…
Title: -
Shares: 235,294
Price/Share: $17.00
Value: $3,999,998.00
Shares Owned: 507,076
Relationship: TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

No institutional ownership data available.

Alamar Biosciences, Inc. (ALMR) — SEC Financial Statements & Analysis

Alamar Biosciences, Inc. (ALMR) is a laboratory analytical instruments company, incorporated in DE. Alamar Biosciences, Inc. trades on Nasdaq as: ALMR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Alamar Biosciences, Inc. reported a Debt-to-Equity ratio of 0.25x, a Price-to-Book (P/B) ratio of 5.08x (TTM), at a market cap of $1.59B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
0.25x
P/B TTM
5.08x
Market Cap
$1.59B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Alamar Biosciences, Inc. in?

Alamar Biosciences, Inc. (ALMR) operates in the Laboratory Analytical Instruments industry.

What is ALMR's market cap?

Alamar Biosciences, Inc. (ALMR) has a market capitalization of $1.59B as of 2026-06-30.

What exchange does ALMR trade on?

Alamar Biosciences, Inc. (ALMR) trades on the Nasdaq.

Where is Alamar Biosciences, Inc. incorporated?

Alamar Biosciences, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.